22778847|t|ACS chemical neuroscience molecule spotlight on dimebon.
22778847|a|Dimebon (latrepirdine) is an antihistamine drug that has been used clinically in Russia since the early 1980s and is being studied jointly by Pfizer and Medivation for patients with Alzheimer's disease. The results from a pivotal Phase 3 clinical trial (CONNECTION) showed that Dimebon (latrepirdine) failed to meet its coprimary or secondary efficacy end points.
22778847	0	3	ACS	Disease	MESH:D000168
22778847	48	55	dimebon	Chemical	MESH:C010119
22778847	57	64	Dimebon	Chemical	MESH:C010119
22778847	66	78	latrepirdine	Chemical	MESH:C010119
22778847	225	233	patients	Species	9606
22778847	239	258	Alzheimer's disease	Disease	MESH:D000544
22778847	335	342	Dimebon	Chemical	MESH:C010119
22778847	344	356	latrepirdine	Chemical	MESH:C010119
22778847	Negative_Correlation	MESH:C010119	MESH:D000544

